Hims & Hers Health (HIMS) Common Equity (2019 - 2026)
Hims & Hers Health's Common Equity history spans 8 years, with the latest figure at $446.2 million for Q1 2026.
- On a quarterly basis, Common Equity fell 18.77% to $446.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $446.2 million, a 18.77% decrease, with the full-year FY2025 number at $540.9 million, up 13.47% from a year prior.
- Common Equity hit $446.2 million in Q1 2026 for Hims & Hers Health, down from $540.9 million in the prior quarter.
- Over the last five years, Common Equity for HIMS hit a ceiling of $581.0 million in Q3 2025 and a floor of $310.9 million in Q3 2022.
- Historically, Common Equity has averaged $404.6 million across 5 years, with a median of $344.5 million in 2024.
- Biggest five-year swings in Common Equity: soared 59.45% in 2025 and later fell 18.77% in 2026.
- Tracing HIMS's Common Equity over 5 years: stood at $311.7 million in 2022, then increased by 10.36% to $344.0 million in 2023, then soared by 38.57% to $476.7 million in 2024, then grew by 13.47% to $540.9 million in 2025, then decreased by 17.52% to $446.2 million in 2026.
- Business Quant data shows Common Equity for HIMS at $446.2 million in Q1 2026, $540.9 million in Q4 2025, and $581.0 million in Q3 2025.